AMPH FY 2019 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMPHAmphastar Pharmaceuticals, Inc.

$860M

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$322M+9.4% YoY

Gross Profit

$132M40.9% margin

Operating Income

-$39,000-0.0% margin

Net Income

$49M15.2% margin

EPS (Diluted)

$0.98

Cash Flow

Operating Cash Flow

$42M

Free Cash Flow

$207,000

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$587M

Total Liabilities

$159M

Stockholders' Equity

$381M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$322M	$295M	+9.4%
Gross Profit	$132M	$107M	+23.3%
Operating Income	-$39,000	-$9M	+99.5%
Net Income	$49M	-$6M	+952.9%